FDA Delays Enforcement of MoCRA’s Registration and Listing Requirements for Six Months | Venable LLP

On November 8, 2023, the United States Food and Drug Administration (FDA or agency) announced it does not intend to enforce the requirements related to cosmetic product facility registration and cosmetic product listing under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) for six months after the December 29, 2023 statutory deadline. In other words, the agency has delayed the deadline for the registration and listing requirements until July 1, 2024. The delayed deadline will help ensure that industry has sufficient time to gather and verify the relevant information required for facility registration and product listing, including obtaining facility registration numbers to associate with cosmetic product listings, and obtaining access to the electronic submission database (electronic registration is strongly encouraged).

The table below reflects the updated key MoCRA deadlines.

The compliance deadlines for other key MoCRA requirements are currently unknown because agency rulemaking is required. The statutory deadlines for the rulemakings are:

In addition to the above rulemakings, FDA also must assess the use and safety of per- and polyfluoroalkyl substances (PFAS) in cosmetic products and, by December 29, 2025, must publish a report summarizing its findings.

Despite the delayed deadline, FDA has advised that it will be ready to accept registration and listing information by December 29 and encourages companies to meet that deadline if they are able to do so. We note that the agency has released some information related to the registration and listing process that will help companies comply with these new requirements. For example, in August, the agency issued draft guidance, which, when finalized, will provide recommendations and instructions to assist with facility registration and product listing requirements.

Leave a Comment

Your email address will not be published. Required fields are marked *